grna design web tools (Benchling Inc)
Structured Review
![TERT deficient isogenic clone generation and characterisation. a Targeting strategy to generate TERT low hiPSC lines with <t>guide</t> <t>RNA</t> <t>and</t> <t>CRISPR/Cas9.</t> b Diagram of the two TERT low clones obtained, TERT low C1 and TERT low C2. c Telomerase activity of TERT low clones via TRAP assay visualisation and quantification show TERT low clones have reduced telomerase activity. Relative telomerase activity is calculated from the following formula [(TRAP sample—negative control)/Internal control (IC) of sample]/[(WT sample—negative control)/Internal control (IC) of WT sample)]*100. Data is shown as mean ± SD, n = 3, **P < 0.01; ANOVA with Tukey’s multiple comparisons test. d Average telomere length of WT and TERT low C1 and low C2 using the Absolute Human Telomere Length Quantification qPCR Assay Kit showing shorter telomeres in TERT low clones. Data is shown as mean ± SD, n = 3, **** P < 0.0001; ANOVA with Tukey’s multiple comparisons test. e Immunostaining of telomeres in WT and TERT low hiPSCs. TERT low clones show a decrease in telomeres compared to WT iPSCs. Scale bar = 20 μm. f Immunostaining of pluripotency markers NANOG and OCT4. Both WT and TERT low hiPSC lines display pluripotent markers. Scale bar = 50 μm](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8800/pmc10998800/pmc10998800__10522_2023_10076_Fig1_HTML.jpg)
Grna Design Web Tools, supplied by Benchling Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/grna design web tools/product/Benchling Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Telomere shortening induces aging-associated phenotypes in hiPSC-derived neurons and astrocytes"
Article Title: Telomere shortening induces aging-associated phenotypes in hiPSC-derived neurons and astrocytes
Journal: Biogerontology
doi: 10.1007/s10522-023-10076-5
Figure Legend Snippet: TERT deficient isogenic clone generation and characterisation. a Targeting strategy to generate TERT low hiPSC lines with guide RNA and CRISPR/Cas9. b Diagram of the two TERT low clones obtained, TERT low C1 and TERT low C2. c Telomerase activity of TERT low clones via TRAP assay visualisation and quantification show TERT low clones have reduced telomerase activity. Relative telomerase activity is calculated from the following formula [(TRAP sample—negative control)/Internal control (IC) of sample]/[(WT sample—negative control)/Internal control (IC) of WT sample)]*100. Data is shown as mean ± SD, n = 3, **P < 0.01; ANOVA with Tukey’s multiple comparisons test. d Average telomere length of WT and TERT low C1 and low C2 using the Absolute Human Telomere Length Quantification qPCR Assay Kit showing shorter telomeres in TERT low clones. Data is shown as mean ± SD, n = 3, **** P < 0.0001; ANOVA with Tukey’s multiple comparisons test. e Immunostaining of telomeres in WT and TERT low hiPSCs. TERT low clones show a decrease in telomeres compared to WT iPSCs. Scale bar = 20 μm. f Immunostaining of pluripotency markers NANOG and OCT4. Both WT and TERT low hiPSC lines display pluripotent markers. Scale bar = 50 μm
Techniques Used: CRISPR, Clone Assay, Activity Assay, TRAP Assay, Negative Control, Control, Immunostaining
